Niva Bupa Health Insurance Company Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 6 Aug 2026 | Insurance | Market Cap: ₹16.2K Cr
The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. Niva Bupa reported a strong PAT growth of 91% under IFRS, rising from Rs.106 crores in FY24 to Rs.203 crores in FY25.
From Niva Bupa Health Insurance Company Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹82.6
Market Cap
₹16.2K Cr
P/E Ratio
92.9
How does Niva Bupa Health Insurance Company Ltd rank in Insurance?
Compare Niva Bupa Health Insurance Company Ltd against every Insurance company this quarter on revenue, margins and earnings-call signals.
Niva Bupa Health Insurance Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹345 Cr.
Full financials →📊 Revenue & Sales Performance
- →The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25.
- →Retail lives covered grew by around 18% in FY25 compared to FY24.
- →Group health (including employer-employee and loan-attached products) has grown faster than retail business with overall growth around 32%.
- →The company continues to expand its distribution network, adding 8,000 agents and 30 new distribution partners in the last quarter.
- →Launch of the new product "Rise" targets the large unserved middle and lower-middle-class segment, expected to drive new customer additions.
- →The Preferred Provider Network is scaling up, now covering 40 cities and nearly 600 hospitals, enhancing value delivery to customers.
- →The company aims to maintain disciplined underwriting and claims management supported by technology and analytics, supporting sustainable growth.
- →Overall, the company expects ongoing growth driven by multi-channel distribution, product innovation, and expanding ecosystem partnerships.
📈 Profitability & Margins
- →Niva Bupa reported a strong PAT growth of 91% under IFRS, rising from Rs.106 crores in FY24 to Rs.203 crores in FY25.
- →Profit under iGAAP also rose significantly by 161%, from Rs.82 crores to Rs.214 crores in FY25.
- →The company improved its combined ratio on a like-to-like basis to 96.1% in FY25, showing better profitability potential.
- →Expense of management is on a downward trajectory, improving by 190 bps each year, currently at 37.4%, with a confident glide path to meet regulatory targets (~35.5%).
- →Continued growth in retail lives (+18%) and GWP (32%) supports earnings momentum.
- →Emphasis on disciplined underwriting, pricing adjustments, and fraud detection is expected to sustain profitability.
- →Investment yield stable at 7.4%, with a strong solvency ratio (3.03x), supporting financial robustness.
- →Management focus on cross-selling, product innovation (e.g., “Rise” product), and expanding distribution further supports medium to long-term earnings growth.
🏗️ Capital Expenditure Plans
💰 Fundraising & Capital Structure
- →The document does not mention any current or planned future fundraising through debt or equity by Niva Bupa Health Insurance Company Limited.
- →The only related information is a mention of a primary capital raise as part of their IPO, which contributed to AUM growth, but no ongoing or future fundraising is indicated.
- →The investment book is currently almost entirely debt, with negligible recent investment in NIFTY ETF, but this relates to investment strategy, not fundraising.
- →No explicit plans or announcements about new debt or equity fundraising are discussed in the provided transcript.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Niva Bupa Health Insurance Company Ltd Q4 FY25 results?
The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. Niva Bupa reported a strong PAT growth of 91% under IFRS, rising from Rs.106 crores in FY24 to Rs.203 crores in FY25.
What is Niva Bupa Health Insurance Company Ltd share price analysis?
Niva Bupa Health Insurance Company Ltd currently shows a neutral. The stock trades at a P/E of 92.9 with a market cap of ₹16,188 Cr. Investors should review the full earnings analysis for detailed insights.
Is Niva Bupa Health Insurance Company Ltd planning capital expenditure?
The provided pages of the Niva Bupa Health Insurance Company Limited document do not explicitly mention any current or future capex, capital investment, or strategic investment plans.
Keep Niva Bupa Health Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.